REMIMAZOLAM GABAA Benzodiazepine Site Receptor Agonist Anesthetic/Sedative

被引：1
|
作者：
Piehl, Estee [1 ]
机构：
[1] Univ Colorado Denver, Dept Anesthesiol, Aurora, CO 80045 USA
来源：
DRUGS OF THE FUTURE | 2013年 / 38卷 / 09期
关键词：
Anesthetic; Benzodiazepine; Sedation; Remimazolam; CNS-7056; CNS; 7056; MIDAZOLAM; PHARMACOKINETICS; PHARMACODYNAMICS; CNS-7056; EFFICACY; SAFETY;
D O I：
10.1358/dof.2013.038.09.1990154
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Remimazolam, also known as CNS-7056, is a novel, ultra-short-acting benzodiazepine. It has a faster onset and shorter duration of action than midazolam, with reliable metabolism to an inactive metabolite, CNS-7054, by plasma esterases. The sedative effects appear typical of benzodiazepines and are dependent on dose, with a wide therapeutic range.
引用
收藏
页码：625 / 630
页数：6
相关论文
共 50 条
  • [31] Impact of membrane cholesterol on binding properties of benzodiazepine and convulsant site ligands to the GABAA receptor:: A discrete binding site?
    Bailey, BW
    Lewis, J
    Mitchell, DC
    BIOPHYSICAL JOURNAL, 2004, 86 (01) : 253A - 253A
  • [32] A GABAA alpha 3 benzodiazepine receptor agonist is anxiolytic in a squirrel monkey conditioned fear paradigm.
    Sheppard, W
    Tye, SJ
    Dias, R
    Stanley, JL
    Lincoln, RJ
    Marshall, G
    Cook, SM
    Hallett, D
    Wafford, KA
    Atack, JR
    Dawson, GR
    Reynolds, DS
    JOURNAL OF PSYCHOPHARMACOLOGY, 2004, 18 (03) : A25 - A25
  • [33] CLONING OF GABAA/BENZODIAZEPINE RECEPTOR SUBUNIT CDNAS
    FUJITA, N
    BURT, D
    DARLISON, M
    GLENCORSE, T
    STEPHENSON, A
    BARNARD, E
    SHOFIELD, P
    SEEBURG, P
    RODRIGUES, H
    RAMACHANDRAN, J
    JAPANESE JOURNAL OF PHARMACOLOGY, 1987, 43 : P126 - P126
  • [34] Benzodiazepine agonist and inverse agonist coupling in GABAA receptors antagonized by increased atmospheric pressure
    Davies, DL
    Alkana, RL
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 469 (1-3) : 37 - 45
  • [35] An orally bioavailable, functionally selective inverse agonist at the benzodiazepine site of GABAA α5 receptors with cognition enhancing properties
    Chambers, MS
    Atack, JR
    Carling, RW
    Collinson, N
    Cook, SM
    Dawson, GR
    Ferris, P
    Hobbs, SC
    O'Connor, D
    Marshall, G
    Rycroft, W
    MacLeod, AM
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (24) : 5829 - 5832
  • [36] Rodent pharmacokinetics and receptor occupancy of the GABAA receptor subtype selective benzodiazepine site ligand L-838417
    Scott-Stevens, P
    Atack, JR
    Sohal, B
    Worboys, P
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2005, 26 (01) : 13 - 20
  • [37] Agonist trapping by GABAA receptor channels
    Bianchi, MT
    Macdonald, RL
    JOURNAL OF NEUROSCIENCE, 2001, 21 (23): : 9083 - 9091
  • [38] Computer-aided design of selective ligands of the benzodiazepine-binding site of the GABAA receptor
    V. I. Chupakhin
    S. V. Bobrov
    E. V. Radchenko
    V. A. Palyulin
    N. S. Zefirov
    Doklady Chemistry, 2008, 422 : 227 - 230
  • [39] Contribution of the α1-GABAA receptor subtype to the pharmacological actions of benzodiazepine site inverse agonists
    Crestani, F
    Assandri, R
    Täuber, M
    Martin, JR
    Rudolph, U
    NEUROPHARMACOLOGY, 2002, 43 (04) : 679 - 684
  • [40] Affinity of various benzodiazepine site ligands in mice with a point mutation in the GABAA receptor γ2 subunit
    Ogris, W
    Pöltl, A
    Hauer, B
    Ernst, M
    Oberto, A
    Wulff, P
    Höger, H
    Wisden, W
    Sieghart, W
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (08) : 1621 - 1629
12345